Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹1,565 Cr₹1,398 Cr₹729 Cr₹582 Cr₹513 Cr

What is the latest Total Current Liabilities ratio of GLAND PHARMA ?

The latest Total Current Liabilities ratio of GLAND PHARMA is ₹1,565 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹1,565 Cr
Mar2024₹1,398 Cr
Mar2023₹729 Cr
Mar2022₹582 Cr
Mar2021₹513 Cr

How is Total Current Liabilities of GLAND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2025 ₹1,565 Cr
11.91
Mar2024 ₹1,398 Cr
91.78
Mar2023 ₹729 Cr
25.28
Mar2022 ₹582 Cr
13.56
Mar2021 ₹513 Cr -

Compare Total Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,621.0 Cr -1.9% -5.1% 13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,862.0 Cr 1.4% 2.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹174,125.0 Cr 7.1% 8.8% 10.3% Stock Analytics
CIPLA ₹125,454.0 Cr 3.9% -1.3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,106.0 Cr -1.3% -1.3% 2.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,263.0 Cr 0.2% -6% -4.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.9%

-5.1%

13.4%

SENSEX

0.1%

0.6%

0.7%


You may also like the below Video Courses